Blog

Quick Facts About PamrevlumabWhat is Pamrevlumab?Pamrevlumab (FG-3019) is a monoclonal antibody designed to target and inhibit the connective tissue growth factor (CTGF), a key driver of fibrosis in diseases like idiopathic pulmonary fibrosis (IPF) and pancreatic cancer.What is the mechanism of action for Pamrevlumab?Pamrevlumab works by binding to CTGF, a protein involved in the fibrotic process. By inhibiting CTGF, it aims to reduce the progression of fibrosis in tissues affected by diseases like IPF and pancreatic cancer.What are the clinical applications of Pamrevlumab?Pamrevlumab is currently under investigation in clinical trials for diseases such as idiopathic pulmonary fibrosis (IPF) and pancreatic cancer, with ongoing studies exploring its potential in Duchenne muscu …